Watch Ticker

Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares

Go to Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares Website

$0.70

0.02 (3.35%)

Live

Previous Close

$0.6745

Day Range

$0.6746 - $0.69705

Previous Day Range

$0.67 - $0.6863

Market Cap

$8.7 million USD

Day Vol.

86816

Previous Day Vol.

84682

Currency

USD

Primary Exchange

NYSE American, LLC

Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's pl...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Can-Fite Biopharma Ltd. - Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits

Can-Fite BioPharma's drug Namodenoson has shown promising results in treating liver cancer, as well as providing protective effects on the heart, liver, and nervous system, unlike traditional chemotherapy. The study highlights Namodenoson's ability to increase adiponectin levels, a key cytokine known to drive multi-organ protective effects.

Related tickers: CANF.

Read Full Article

N/A - Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025

Can-Fite BioPharma, a biotechnology company, announced that it will present its lead drug candidate Namodenoson, which is in late-stage trials for liver cancer and metabolic disorders, at the upcoming BIO CEO & Investor Conference.

Related tickers: CANF.

Read Full Article

Trending Tickers

Please sign in to view